Skip to main content

Research Repository

Advanced Search

TIGA-CUB – manualised psychoanalytic child psychotherapy versus treatment as usual for children aged 5–11 years with treatment-resistant conduct disorders and their primary carers: study protocol for a randomised controlled feasibility trial

Edginton, Elizabeth; Walwyn, Rebecca; Burton, Kayleigh; Cicero, Robert; Graham, Liz; Reed, Sadie; Tubeuf, Sandy; Twiddy, Maureen; Wright-Hughes, Alex; Ellis, Lynda; Evans, Dot; Hughes, Tom; Midgley, Nick; Wallis, Paul; Cottrell, David

Authors

Elizabeth Edginton

Rebecca Walwyn

Kayleigh Burton

Robert Cicero

Liz Graham

Sadie Reed

Sandy Tubeuf

Alex Wright-Hughes

Lynda Ellis

Dot Evans

Tom Hughes

Nick Midgley

Paul Wallis

David Cottrell



Abstract

Background: The National Institute for Health and Care Excellence (NICE) recommends evidence-based parenting
programmes as a first-line intervention for conduct disorders (CD) in children aged 5–11 years. As these are not
effective in 25–33% of cases, NICE has requested research into second-line interventions. Child and Adolescent
Psychotherapists (CAPTs) address highly complex problems where first-line treatments have failed and there have
been small-scale studies of Psychoanalytic Child Psychotherapy (PCP) for CD. A feasibility trial is needed to
determine whether a confirmatory trial of manualised PCP (mPCP) versus Treatment as Usual (TaU) for CD is
practicable or needs refinement. The aim of this paper is to publish the abridged protocol of this feasibility trial.
Methods and design: TIGA-CUB (Trial on improving Inter-Generational Attachment for Children Undergoing
Behaviour problems) is a two-arm, pragmatic, parallel-group, multicentre, individually randomised (1:1) controlled
feasibility trial (target n = 60) with blinded outcome assessment (at 4 and 8 months), which aims to develop an
optimum practicable protocol for a confirmatory, pragmatic, randomised controlled trial (RCT) (primary outcome:
child’s behaviour; secondary outcomes: parental reflective functioning and mental health, child and parent quality
of life), comparing mPCP and TaU as second-line treatments for children aged 5–11 years with treatment-resistant
CD and inter-generational attachment difficulties, and for their primary carers. Child-primary carer dyads will be
recruited following a referral to, or re-referral within, National Health Service (NHS) Child and Adolescent Mental
Health Services (CAMHS) after an unsuccessful first-line parenting intervention. PCP will be delivered by qualified
CAPTs working in routine NHS clinical practice, using a trial-specific PCP manual (a brief version of established PCP
clinical practice). Outcomes are: (1) feasibility of recruitment methods, (2) uptake and follow-up rates, (3) therapeutic
delivery, treatment retention and attendance, intervention adherence rates, (4) follow-up data collection, and
(5) statistical, health economics, process evaluation, and qualitative outcomes.
Discussion: TIGA-CUB will provide important information on the feasibility and potential challenges of undertaking
a confirmatory RCT to evaluate the effectiveness and cost-effectiveness of mPCP.

Citation

Edginton, E., Walwyn, R., Burton, K., Cicero, R., Graham, L., Reed, S., …Cottrell, D. (2017). TIGA-CUB – manualised psychoanalytic child psychotherapy versus treatment as usual for children aged 5–11 years with treatment-resistant conduct disorders and their primary carers: study protocol for a randomised controlled feasibility trial. Trials, 18(1), Article 431. https://doi.org/10.1186/s13063-017-2166-2

Journal Article Type Article
Acceptance Date Aug 30, 2017
Online Publication Date Sep 15, 2017
Publication Date Sep 15, 2017
Deposit Date Jan 5, 2018
Publicly Available Date Jan 15, 2018
Journal Trials
Print ISSN 1745-6215
Electronic ISSN 1745-6215
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 18
Issue 1
Article Number 431
DOI https://doi.org/10.1186/s13063-017-2166-2
Keywords Medicine (miscellaneous); Pharmacology (medical)
Public URL https://hull-repository.worktribe.com/output/499584
Publisher URL https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-017-2166-2

Files

Published article (1.5 Mb)
PDF

Copyright Statement
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.





You might also like



Downloadable Citations